Breast cancer is not a single disease, but a group of tumours with different biological characteristics, and its treatment needs to be formulated with precision based on specific spectrometry.
I. Hormonal receptor positive breast cancer
These breast cancer cells have estrogen receptors (ERs) and/or congener receptors (PRs). Common treatments include endocrinological treatment, such as the use of drugs such as his mossophene to inhibit the growth of tumours by disrupting the association of estrogens with receptors. For post-menopausal women, aromatic enzyme inhibitors are also commonly used. Some patients may also undergo chemotherapy before being treated for endocrine maintenance in order to reduce the risk of relapse and extend their survival.
II. HER – 2 Positive Breast Cancer
Her – 2 is human skin growth factor receptor 2. For this type of breast cancer, anti-HER-2 targets play a key role in the treatment of drugs, such as the one-size-fits-all. Monopharmaceuticals can be used and are often associated with chemotherapy. Newly assisted treatment can reduce the tumours and increase the rate of surgical excision and breast milk. The risk of relapse and death is significantly reduced when assisted treatment is provided. In addition, there are new types of antibodies that can more precisely transfer cytotoxics to tumour cells to enhance therapeutic efficacy.
III. Third-negative breast cancer
chemotherapy is the main means of treatment due to the lack of ER, PR and HER-2 expression and the ineffectiveness of endocrine treatment and anti-HER-2 target treatment. Co-programs of rims and pheasants are commonly used. In recent years, immunisation treatment has progressed in some cases in the form of anti-negative breast cancers, and attacks on tumour cells have been carried out through the activation of their own immune system. However, there is still a need to explore more effective treatments for three-negative breast cancers, which are relatively high in severity and risk of recurrence.
IV. Special types of breast cancer
Inflammatory breast cancer, for example, is a rapid development and is often treated with chemotherapy, surgery and leaching before the tumor is reduced. In situ folate cancer is generally closely observed or endocrine treatment to prevent it from developing into immersive cancer.
In short, the styling of breast cancer is an expression of modern medical precision. By making an accurate diagnosis of the type of breast cancer, doctors are able to develop individualized treatment programmes for patients, thus increasing the effectiveness of treatment, reducing the rate of relapse, extending the duration of life of patients and improving the quality of life. Patients ‘ knowledge of stylist treatment also contributes to a better understanding of their condition and active cooperation in treatment.
